sub_logo
 

Directions / Map

 
 

For general information, call (781) 402-5700.

For business development, please send an email to
busdev@crtx.com.

For investor relations, please send an email to investor.relations@crtx.com.

If you are a security holder of Critical Therapeutics, Inc., you are invited to communicate with our Board of Directors regarding Critical Therapeutics by writing to the following address:

ATTN: Board of Directors
Critical Therapeutics, Inc.
60 Westview Street
Lexington, MA 02421

You can report your complaints or concerns anonymously or confidentially. If you provide us with contact information, you will receive a written acknowledgement upon receipt of your complaint or concern.

 
Home | About | Products | Development Pipeilne | News | Investors | Careers

© 2007 Critical Therapeutics, Inc. All rights reserved.
For ZYFLO® (zileuton tablets) prescribing information, click here .
For ZYFLO CR™ (zileuton) extended-release tablets, click here.
For Terms of Use and Disclaimer, click here.
For Privacy Policy,
click here.
This site is intended for residents of the United States, Puerto Rico
and U.S. territories.